Biological Clock and Reproductive Longevity: Molecular Insights into Ovarian Aging and the Role of Physical Activity
DOI:
https://doi.org/10.12775/QS.2026.54.70260Keywords
female fertility; female fertility; reproductive aging; ovarian reserve; oocyte quality; assisted reproductive technology; oocyte cryopreservationAbstract
Introduction. The "biological clock" remains the primary determinant of female reproductive potential, as fertility is strictly limited by a finite pool of oocytes. In modern society, including professional athletes, the trend toward delayed childbearing has increased the clinical relevance of age-related fertility decline. This review explores the molecular foundations of ovarian aging and the impact of lifestyle on reproductive longevity.
Materials and Methods. A narrative review was conducted using PubMed and Google Scholar, focusing on clinical guidelines (ASRM, ESHRE) and recent research regarding oocyte depletion, biomarkers (AMH, AFC), and the influence of physical activity and psychosocial stress on fertility outcomes.
Literature Review. Reproductive aging is driven by oxidative stress, mitochondrial dysfunction (reduced ATP production), and degradation of cohesin proteins, leading to increased embryonic aneuploidy and miscarriage rates. While AMH and AFC are reliable for assessing follicle quantity, they remain limited in predicting oocyte quality or spontaneous conception. In active populations, extreme physical exertion and psychological pressure can modulate the ovarian microenvironment, potentially affecting reproductive success and long-term quality of life.
Summary and Conclusions. Despite advancements in ART, female age remains the most critical predictor of fertility. To optimize reproductive longevity, it is essential to integrate early fertility education and individualized counseling into the routine medical care of active women.
References
[1] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile female: a committee opinion. Fertil Steril. 2021;116, 1255 1265. https://doi.org/10.1016/j.fertnstert.2021.08.038
[2] Practice Committee of the American Society for Reproductive Medicine. Female age-related fertility decline. Fertil Steril. 2014; 101, 633-634
https://doi.org/10.1016/j.fertnstert.2013.12.032
[3] Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, Scott RT Jr. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014 Mar;101(3):656-663.e1.
https://doi.org/10.1016/j.fertnstert.2013.11.004.
[4] Egbert R. te Velde, Peter L. Pearson, The variability of female reproductive ageing, Human Reproduction Update, Volume 8, Issue 2, 1 March 2002, Pages 141–154,
https://doi.org/10.1093/humupd/8.2.141
[5] Owen A, Carlson K, Sparzak PB. Age-Related Fertility Decline. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 35015465.
https://pubmed.ncbi.nlm.nih.gov/35015465/
[6] Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society for Reproductive Endocrinology and Infertility. Optimizing natural fertility: a committee opinion. Fertil Steril. 2017 Jan;107(1):52-58.
https://doi.org/10.1016/j.fertnstert.2016.09.029.
[7] Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020 Dec;114(6):1151-1157
https://doi.org/10.1016/j.fertnstert.2020.09.134
[8] Ethics Committee of the American Society for Reproductive Medicine. Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion. Fertility and Sterility, 2024; 121, 604-612
https://doi.org/10.1016/j.fertnstert.2023.12.030
[9] ESHRE Guideline Group. Ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020, hoaa009.
https://doi.org/10.1093/hropen/hoaa009
[10] ESHRE Guideline Group. Female fertility preservation: ESHRE guideline. Hum Reprod Open. 2020 Nov 14;2020(4):hoaa052,
https://doi.org/10.1093/hropen/hoaa052
[11]Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One.2010;5(1):e8772.
https://doi.org/10.1371/journal.pone.0008772
[12] Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab. 2007 Mar;18(2):58-65
https://doi.org/10.1016/j.tem.2007.01.004
[13] Kelsey TW, Wright P, Nelson SM, et al. A validated model of serum anti-Müllerian hormone from conception to menopause. PLoS One. 2011;6(7):e22024.
https://doi.org/10.1371/journal.pone.0022024
[14] Cimadomo D, Fabozzi G, Vaiarelli A, et al. Impact of Maternal Age on Oocyte and Embryo Competence. Front Endocrinol (Lausanne). 2018;9:327.
https://doi.org/10.3389/fendo.2018.00327
[15] Broer SL, Broekmans FJ, Laven JS, et al. Anti-Müllerian hormone: ovarian reserve testing and its clinical implications. Hum Reprod Update. 2014;20(5):688-701.
https://doi.org/10.1093/humupd/dmu020
[16] Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014;20(3):370-385.
https://doi.org/10.1093/humupd/dmt062
[17] Yan F, Zhao Q, Li Y, Zheng Z, Kong X, Shu C, Liu Y, Shi Y. The role of oxidative stress in ovarian aging: a review. J Ovarian Res. 2022 Sep 1;15(1):100
https://doi.org/10.1186/s13048-022-01032-x
[18] reff NR, Franasiak JM. Detection of segmental aneuploidy and mosaicism in the human preimplantation embryo: technical considerations and limitations. Fertil Steril. 2017 Jan;107(1):27-31
https://doi.org/10.1016/j.fertnstert.2016.09.039
[19] Ju W, Zhao Y, Yu Y, Zhao S, Xiang S, Lian F. Mechanisms of mitochondrial dysfunction in ovarian aging and potential interventions. Front Endocrinol (Lausanne). 2024 Apr 17;15:1361289
https://doi.org/10.3389/fendo.2024.1361289
[20] Anderson RA, Cameron D, Clatot F, Demeestere I, Lambertini M, Nelson SM, Peccatori F. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Hum Reprod Update. 2022 May 2;28(3):417-434
https://doi.org/10.1093/humupd/dmac004
[21] La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20(1):124-140. https://doi.org/10.1093/humupd/dmt037
[22] Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2015;103(6):e44-e50. https://doi.org/10.1016/j.fertnstert.2015.03.019
[23] Cobo A, Garcia-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105(3):755-764.
https://doi.org/10.1016/j.fertnstert.2015.11.027
[24] Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013;99(4):963-969.
https://doi.org/10.1016/j.fertnstert.2012.11.051
[25] Steiner AZ, Pritchard DA, Stanczyk FZ, et al. Association between biomarkers of ovarian reserve and fertility among older women of reproductive age. JAMA. 2017;318(14):1367-1376.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Zuzanna Panas, Izabela Ślinko, Gabriela Kuliś, Ewa Dryl Jarmoc, Kacper Krawczuk, Jakub Dziemiańczuk, Mateusz Zimowski, Piotr Kadysz, Agata Kolanek, Mateusz Czajkowski

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 59
Number of citations: 0